Search Results - "Tronieri JS"

Short- and long-term effects of semaglutide 2.4 mg on energy intake, appetite, and food reward: a 60-week, double-blind randomized controlled trial.

Authors: Tronieri JS Allison KC DeRouen K et al.

Source: The American journal of clinical nutrition [Am J Clin Nutr] 2026 Jun 20, pp. 101403. Date of Electronic Publication: 2026 Jun 20.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0376027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-3207 (Electronic) Linking ISSN: 00029165 NLM ISO Abbreviation: Am J Clin Nutr Subsets: MEDLINE

Correlates of Healthcare Patients' Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss.

Authors: Wilkins, Francesca L. Moore, Wendy S. Jackson, Jalen R. et al.

Source: American Journal of Health Promotion. Jun2026, Vol. 40 Issue 5, p576-590.

Drug-induced gastric motility disorders: A disproportionality analysis from the FAERS and CVARD databases.

Authors: Qian, Zhiheng Jiang, Ni

Source: PLoS ONE. 6/21/2026, Vol. 21 Issue 6, p1-22. 22p.

Meta-analysis of the effects of semaglutide on body mass index (BMI) and blood lipid levels in polycystic ovary syndrome patients.

Authors: Chen, Wansu Xu, Dan Shao, Xueting et al.

Source: Gynecological Endocrinology. Dec2025, Vol. 41 Issue 1, p1-13. 13p.

Euthyroid Sick Syndrome Precipitated By Rapid Weight Loss Following Semaglutide Initiation: A Case Report.

Authors: Elmezayen, Ziad W. Qrareya, Farah Abdallah, Abdallah et al.

Source: Clinical Medicine Insights: Endocrinology & Diabetes. 4/22/2026, Vol. 19, p1-5. 5p.

Patient experiences with liraglutide for obesity and binge eating disorder–A qualitative study.

Authors: Følling, Ingrid Sørdal Reigstad, Stine Larsen Hyldmo, Åsne Ask et al.

Source: PLoS ONE. 10/31/2025, Vol. 20 Issue 10, p1-12. 12p.

A multidisciplinary protocol for reducing excessive and maintaining a healthy body weight in the personalized management of chronic diseases in children and adults.

Authors: Banić, Ivana Jankić, Marija Miletić Gospić, Adrijana et al.

Source: PLoS ONE. 3/13/2025, Vol. 20 Issue 3, p1-11. 11p.

2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies.

Authors: Valerio, Cynthia M. Saraiva, Jose F. K. Valente, Fernando et al.

Source: Diabetology & Metabolic Syndrome. 11/18/2025, Vol. 17 Issue 1, p1-21. 21p.

Co-development of an acceptance and commitment therapy-based intervention to increase intrinsic motivation of adolescents to change weight: The AIM2Change study.

Authors: Cox, Jennifer S. Searle, Aidan J. Iturbe, Idoia et al.

Source: PLoS ONE. 11/3/2025, Vol. 20 Issue 10, p1-16. 16p.

Breaking the weight of therapeutic inertia: obesity management in cardiology practice.

Alternate Title: Rompiendo el peso de la inercia terapéutica: abordaje de la obesidad en la práctica cardiológica.

Authors: Garagoli, Fernando Bluro, Ignacio Fiorini, Norberto et al.

Source: Medicina (Buenos Aires). sep/oct2025, Vol. 85 Issue 5, p978-990. 13p.

Subjects: OBESITY, CARDIOLOGY, DRUG therapy, BODY mass index, BARIATRIC surgery, TREATMENT delay (Medicine), BEHAVIOR modification

Geographic Terms: ARGENTINA

Semaglutide, tirzepatide, and retatrutide attenuate the interoceptive effects of alcohol in male and female rats.

Authors: Windram, McKinley Lovelock, Dennis F. Carew, Joseph M. et al.

Source: Psychopharmacology. May2026, Vol. 243 Issue 5, p1185-1197. 13p.

Pharmacological interventions for addressing pediatric and adolescent obesity: A systematic review and network meta-analysis.

Authors: Yang, Shuo Xin, Shuangqing Ju, Ronghui et al.

Source: PLoS ONE. 2/27/2025, Vol. 20 Issue 2, p1-15. 15p.

Comparing the Impact of GLP-1 Agonists vs. Lifestyle Interventions and Weight Controllability Information on Stigma and Weight-Related Cognitions.

Authors: Post, Stacy M. Stock, Michelle L. Persky, Susan

Source: International Journal of Behavioral Medicine. Aug2025, Vol. 32 Issue 4, p528-540.

Remission of Hypertension Through Lifestyle Modification: A Case Study.

Authors: N. A., Yunus Y. Y., Ng

Source: IIUM Medical Journal Malaysia. Oct2025, Vol. 24 Issue 4, p148-152. 5p.

Effectiveness of an Individualized Comprehensive Weight Management Program in Perimenopausal Women: An Open-label Randomized Control Trial.

Authors: Verma, Aditi Ranjan, Piyush Kumari, Archana et al.

Source: Journal of Mid-life Health. Oct-Dec2025, Vol. 16 Issue 4, p434-444. 11p.

Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development.

Authors: Sills, E. Scott Harrity, Conor Chu, Howard I. et al.

Source: Reproductive Biology & Endocrinology. 8/8/2025, Vol. 23 Issue 1, p1-8. 8p.

Both subcutaneous semaglutide and calorie restriction improves pancreatic cell hyperplasia and gut microbiota in high-fat diet-induced obese mice.

Authors: Luo, Yunfei Yang, Shiqi Zeng, Haixia et al.

Source: Nutrition & Metabolism. 8/7/2025, Vol. 22 Issue 1, p1-11. 11p.

Effect of glucagon‐like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta‐analysis.

Authors: Ali, Abraish Siddiqui, Asad Ali Usman, Muhammad Shariq et al.

Source: Clinical Obesity. Aug2025, Vol. 15 Issue 4, p1-10. 10p.

Characterising first, recent and worst experiences of weight stigma in a clinical sample of adults with high body weight and high internalised stigma.

Authors: Pearl, Rebecca L. Groshon, Laurie C. Hernandez, Marian et al.

Source: Clinical Obesity. Aug2025, Vol. 15 Issue 4, p1-12. 12p.

Correlation between SLC39A8 gene and body constitution-related phenotypes and hearing loss: a Mendelian randomization-based study.

Authors: Li, Dan Xu, Hui Li, Heng et al.

Source: Archives of Medical Science. 2025, Vol. 21 Issue 4, p1-10. 10p.